Global Endotoxin Testing Market Size To Exceed USD 3.35 Billion By 2033 | CAGR of 4.49%
Category: HealthcareGlobal Endotoxin Testing Market Size To Exceed USD 3.35 Billion By 2033
According to a research report published by Spherical Insights & Consulting, the Global Endotoxin Testing Market Size Expected to Grow from USD 2.16 Billion in 2023 to USD 3.35 Billion by 2033, at a CAGR of 4.49% during the forecast period 2023-2033.
Get more details on this report -
Browse key industry insights spread across 220 pages with 111 Market data tables and figures & charts from the report on the " Global Endotoxin Testing Market Size, Share, and COVID-19 Impact Analysis, By Technology (Gel Clot Endotoxin Testing, Chromogenic Endotoxin Testing, Turbidimetric Endotoxin Testing, and Others), By End Users (Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROs), and Medical Device Manufacturers), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033. " Get Detailed Report Description Here: https://www.sphericalinsights.com/reports/endotoxin-testing-market
The bacterial endotoxins test (BET), another name for endotoxin testing, is an in vitro process used to assess the levels of bacterial endotoxins in items, particularly pharmaceuticals and medical equipment, to ensure that safety and quality criteria are met. This analysis helps users and patients avoid any unfavourable outcomes. Additionally, the growing prevalence of infections associated with healthcare is expected to fuel future growth in the endotoxin testing market. Healthcare-associated infections are illnesses that were not present at the time of hospitalization but were acquired during medical treatment. Since contaminated medical procedures or equipment are often the cause of healthcare-associated infections, extensive testing is required to ensure patient safety. However, the high cost of treatments is limiting the growth of the endotoxin testing market during the forecast period. Exorbitant treatment costs may reduce demand for various medical products and therapies, including endotoxin testing.
The gel clot endotoxin testing segment is anticipated to hold the largest share of the global endotoxin testing market during the projected timeframe.
On the basis of technology, the global endotoxin testing market is categorized as gel clot endotoxin testing, chromogenic endotoxin testing, turbidimetric endotoxin testing, and others. Among these, the gel clot endotoxin testing segment is anticipated to hold the largest share of the global endotoxin testing market during the projected timeframe. This is due to its affordability and ease of use, the gel clot technique is still often employed for routine testing. Because they produce quantitative data with high sensitivity, turbidimetric and chromogenic methods are employed in automated and high-throughput settings.
The pharmaceutical and biotechnology companies’ segment is expected to grow at the fastest CAGR during the projected timeframe.
On the basis of end user, the global endotoxin testing market is categorized as pharmaceutical and biotechnology companies, contract research organizations (CROs), and medical device manufacturers. Among these, the pharmaceutical and biotechnology companies segment is expected to grow at the fastest CAGR during the projected timeframe. Pharmaceutical and biotechnology companies take a significant amount of this into account because of the expanding production of medications and biologics, which require strict endotoxin testing to ensure safety and compliance.
North America is projected to hold the largest share of the global endotoxin testing market over the forecast period.
Get more details on this report -
North America is projected to hold the largest share of the global endotoxin testing market over the forecast period. This dominance stems from a well-established biotechnology and pharmaceutical sector, as well as tight regulatory frameworks implemented by authorities such as the United States Food and Drug Administration (FDA). The region's robust healthcare system, significant investments in drug discovery, and strong demand for biologics and medical devices are the main factors propelling the market.
Europe is expected to grow at the fastest CAGR growth of the global endotoxin testing market during the forecast period. The European Medicines Agency (EMA) has strict endotoxin testing criteria to ensure product safety and compliance. Because of their significant investments in biopharmaceuticals and growing emphasis on natural and recombinant endotoxin testing alternatives, Germany, France, and the UK are significant countries propelling the market's upward trajectory.
Major vendors in the global endotoxin testing market are Thermo Fisher Scientific Inc., Merck KGaA, bioMérieux SA, Eurofins Scientific SE, Lonza Group Ltd., WuXi AppTec Co. Ltd., Bio-Rad Laboratories Inc., Maravai LifeSciences Holdings Inc., Cambrex Corporation, GenScript Biotech Corporation, Charles River Laboratories International Inc., Nelson Laboratories LLC, and Others.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Recent Developments
- In January 2022, the US-based water treatment company SUEZ Water Technologies and Solutions paid an undisclosed amount to acquire Sentinel Monitoring Systems Inc. This acquisition increases the range of analytical tools that Veolia Water Technologies & Solutions offers and opens up new markets for microbiological surveillance.
Market Segment
This study forecasts revenue at global, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the global endotoxin testing market based on the below-mentioned segments:
Global Endotoxin Testing Market, By Technology
- Gel Clot Endotoxin Testing
- Chromogenic Endotoxin Testing
- Turbidimetric Endotoxin Testing
- Others
Global Endotoxin Testing Market, By End User
- Pharmaceutical and Biotechnology Companies
- Contract Research Organizations (CROs)
- Medical Device Manufacturers
Global Endotoxin Testing Market, By Regional
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?